Results 151 to 160 of about 118,987 (263)

Surface Plasmon Resonance (SPR) Workflow for Comparative Analysis of Nanobody Variants Binding to Lysozyme as a Model Ligand. [PDF]

Curr Protoc
Díaz-Galicia E, Gutu N, Peng Y, Valitova A, Renn D, Rueping M.   +5 more
europepmc   +1 more source

Genetic analysis of primary lung interdigitating dendritic cell sarcomas

The Journal of Pathology, EarlyView.
Abstract Interdigitating dendritic cell sarcomas (IDCSs) are rare tumors that commonly arise in the hematopoietic system and rarely outside. The genetic drivers of IDCS carcinogenesis are unknown; therefore, therapeutic options are limited. We investigated somatic gene mutations and copy‐number alterations (CNAs) in nine IDCSs arising in the lung by ...
Mikhail S Ermakov, Juliana Faria Filipe, Sylvia Eidenhammer, German Ott, Iris Halbwedl, Karl Kashofer, Helmut Popper   +6 more
wiley   +1 more source

Functional protein design and enhancement with ontology reinforcement iteration. [PDF]

Nat Commun
He B, Qin C, Zhao Y, Huang LK, Wu Z, Wang F, Wu F, Yang F, Yao J.   +8 more
europepmc   +1 more source

Biodegradable Dual‐Material 4D‐Printed Scaffolds With Tunable PLA/PEG Ratios for Mandibular Bone Regeneration

Polymer Engineering &Science, EarlyView.
Schematic representation of the fabrication and application concept of biodegradable dual‐material 4D‐printed PLA/PEG scaffolds for mandibular bone regeneration. ABSTRACT In this study, biodegradable dual‐material 4D‐printed scaffolds with tunable poly(lactic acid)/poly(ethylene glycol) (PLA/PEG) ratios were designed, fabricated, and systematically ...
Meltem Eryildiz
wiley   +1 more source

Effect of Microwave on Protein Conformations and Enzymatic Reactions. [PDF]

Molecules
Kayamori F, Usui K.
europepmc   +1 more source

Boron‐10 carriers and their applications in boron neutron capture therapy

Precision Radiation Oncology, EarlyView.
Summary of different types of boron drugs. Abstract Boron neutron capture therapy (BNCT) has emerged as a promising therapeutic modality in cancer treatment, demonstrating the ability to selectively eliminate cancer cells through the 10B(n,α)7Li nuclear reaction with minimal side effects on normal tissues.
Dachao Tang, Mengqi Shi, Zhichen Mao, Weiya Chen, Xiaoling Li, Xiao Yan Zhao, Zhigang Liu, Xiao Xu   +7 more
wiley   +1 more source

Versatility of TiO₂ Nanoparticles Surfaces in ACN, DMSO, and Aqueous Natural Secretions: Colloidal Behavior. [PDF]

ACS Omega
Laguta A.
europepmc   +1 more source

The Mycobacterium tuberculosis Rv0132c Gene Product Mtb‐FGD2 Can Act as an F420‐Dependent Glucose Dehydrogenase

Proteins: Structure, Function, and Bioinformatics, EarlyView.
ABSTRACT The role of the cell envelope‐associated Rv0132c/FGD2 from Mycobacterium tuberculosis has long been a subject of debate. Importantly, FGD2 is found only in pathogenic mycobacteria, making it a potential drug target. While some suggest it functions as a glucose‐6‐phosphate dehydrogenase, others propose it acts instead as an F420‐dependent ...
Adewale V. Aderemi, Matthew Snee, Richard B. Tunnicliffe, Linus O. Johanissen, Matthew J. Cliff, Colin W. Levy, Derren J. Heyes, Marina Golovanova, Thomas A. Jowitt, Sam Hay, Andrew W. Munro, Jonathan P. Waltho, David Leys   +12 more
wiley   +1 more source

Lysozyme [PDF]

Proceedings of the Royal Society of Medicine, 1932
openaire   +1 more source

Analysis of glutamine synthetase target‐site mutations and their role in endowing glufosinate‐ammonium resistance

Pest Management Science, EarlyView.
GS2.2 G255D mutation conferred enzyme‐level glufosinate insensitivity but no whole‐plant resistance, showing trade‐offs between catalytic function and herbicide binding and providing a baseline for future studies on target‐site glufosinate resistance.
Aimone Porri, Susee Sudhakar, Matheus M Noguera, Michael Betz, Jens Lerchl, Franck E Dayan, Ingo Meiners, Tino Caldarelli, Jason Norsworthy   +8 more
wiley   +1 more source